Development of a novel RNA-based microsatellite stable predictive response signature (MSS-PRS) to identify MSS colorectal cancer (CRC) patients with a microsatellite instability-high (MSI-H) molecular phenotype

被引：0
|
作者：
Pappan, Kirk
Mayhew, Gregory
Shepherd, Jonathan
Guo, Yuelong
Beebe, Kirk
Eisner, Joel
Milburn, Michael
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1040
引用
收藏
页数：2
相关论文
共 43 条
  • [31] SEAMARK: Randomized phase 2 study of pembrolizumab plus encorafenib plus cetuximab vs pembrolizumab alone for first-line treatment of BRAF V600E-mutant microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC).
    Kopetz, Scott
    Bekaii-Saab, Tanios S.
    Yoshino, Takayuki
    Chung, Chin-Hee
    Zhang, Xiaosong
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS268 - TPS268
  • [32] SEAMARK: Randomized phase 2 study of pembrolizumab plus encorafenib plus cetuximab versus pembrolizumab alone for first-line treatment of BRAF V600E-mutant and microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC)
    Kopetz, Scott
    Bekaii-Saab, Tanios S.
    Yoshino, Takayuki
    Chung, Chin-Hee
    Zhang, Xiaosong
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR/MSI-H Immunotherapy (COMMIT) Study: A Randomized Phase 3 Study of mFOLFOX6/Bevacizumab/Atezolizumab Combination vs Single Agent Atezolizumab in the First-Line Treatment of Patients With Deficient DNA Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer (NCT02997228).
    不详
    ONCOLOGY-NEW YORK, 2021, 35 (06): : 367 - 367
  • [34] First-line (1L) nivolumab (NIVO) plus ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): 64-month (mo) follow-up from CheckMate 142
    Lenz, Heinz-Josef
    Overman, Michael J.
    Van Cutsem, Eric
    Limon, Maria Luisa
    Wong, Ka Yeung Mark
    Hendlisz, Alain
    Aglietta, Massimo
    Garcia-Alfonso, Pilar
    Neyns, Bart
    Gelsomino, Fabio
    Cardin, Dana Backlund
    Dragovich, Tomislav
    Shah, Usman
    McCraith, Stephen
    Wang, Rui
    Lei, Ming
    Yao, Jin
    Jin, Lixian
    Lonardi, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 97 - 97
  • [35] Exploratory Analysis of Janus Kinase 1 (JAK1) Loss-of-Function (LoF) Mutations in Patients with DNA Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Metastatic Colorectal Cancer (mCRC) Treated with Nivolumab plus Ipilimumab in CheckMate-142
    Kopetz, S.
    Andre, T.
    Overman, M. J.
    Zagonel, V.
    Lonardi, S.
    Aglietta, M.
    Gelsomino, F.
    McDermott, R.
    Wong, K. Y. M.
    Hendlisz, A.
    Alfonso, P. G.
    Lenz, H. J.
    Walsh, A.
    Moss, R. A.
    Greenawalt, D.
    Cao, Z. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (03): : S3 - S3
  • [36] Exploratory analysis of Janus kinase 1 (JAK1) loss-of-function (LoF) mutations in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC) treated with nivolumab plus ipilimumab in CheckMate-142
    Kopetz, Scott
    Andre, Theirry
    Overman, Michael J.
    Zagonel, Vittorina
    Lonardi, Sara
    Aglietta, Massimo
    Gelsomino, Fabio
    McDermott, Ray
    Wong, Ka Yeung Mark
    Hendlisz, Alain
    Garcia Alfonso, Pilar
    Lenz, Heinz-Josef
    Walsh, Alice
    Moss, Rebecca A.
    Greenawalt, Danielle
    Cao, Z. Alexander
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H) and/or deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Phase III KEYNOTE-177 study
    Andre, T.
    Amonkar, M.
    Norquist, J.
    Shiu, K-K.
    Kim, T. W.
    Jensen, B. V.
    Jensen, L. H.
    Punt, C. J.
    Smith, D.
    Garcia-Carbonero, R.
    Sevilla, I.
    de la Fouchardiere, C.
    Rivera, F.
    Elez, E.
    Diaz, L. A.
    Yoshino, T.
    Van Cutsem, E.
    Yang, P.
    Farooqui, M. Z. H.
    Le, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S409 - S409
  • [38] First-line (1L) nivolumab (NIVO) plus ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): 64-month (mo) follow-up from CheckMate 142
    Lenz, Heinz-Josef
    Overman, Michael J.
    Van Cutsem, Eric
    Limon, M. Luisa
    Wong, Mark Ka
    Hendlisz, Alain
    Aglietta, Massimo
    Garcia-Alfonso, Pilar
    Neyns, Bart
    Gelsomino, Fabio
    Cardin, Dana Backlund
    Dragovich, Tomislav
    Shah, Usman
    McCraith, Stephen M.
    Wang, Abigail
    Lei, Ming
    Yao, Jin
    Jin, Lixian
    Lonardi, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Health-related quality of life (HRQoL) with first-line (1L) nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): CheckMate 8HW
    Lonardi, S.
    Andre, T.
    Arnold, D.
    Garcia-Carbonero, R.
    Chalabi, M.
    Elez Fernandez, M. E.
    Lenz, H. J.
    Jensen, L. H.
    Joshi, R.
    Roodhart, J. M. L.
    Yoshino, T.
    Dixon, M.
    Blum, S. I.
    Sims, J.
    Lawrance, R.
    Taylor, F.
    Chen, T.
    Cela, E.
    Jin, L.
    Van Cutsem, E.
    ANNALS OF ONCOLOGY, 2024, 35 : S1 - S2
  • [40] Subgroup analyses of patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC) treated with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line (1L) therapy:Two-year clinical update.
    Lenz, Heinz-Josef
    Lonardi, Sara
    Zagonel, Vittorina
    Van Cutsem, Eric
    Limon, Luisa M.
    Wong, Ka Yeung Mark
    Hendlisz, Alain
    Aglietta, Massimo
    Garcia-Alfonso, Pilar
    Neyns, Bart
    Luppi, Gabriele
    Cardin, Dana Backlund
    Dragovich, Tomislav
    Shah, Usman
    Yang Jing
    Memaj, Arteid
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
12345